By: Benzinga
Bacterin Highlights Clinical Results for OsteoSponge in 'Journal of Foot & Ankle Surgery'
Bacterin International Holdings, Inc. (NYSE: BONE ), a leader in the development of revolutionary bone graft material and antimicrobial coatings for medical applications, announces that the first clinical results using the OsteoSponge^® product for foot and ankle arthrodesis have been published in The Journal of Foot & Ankle Surgery. The article reports a
Related Stocks:
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Six Financial
Postage Rates Bots go here